Evidence map›Paper›PMID 25698726›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2015

Interleukin 1 type 1 receptor restore: a genetic mouse model for studying interleukin 1 receptor-mediated effects in specific cell types.

Xiaoyu Liu, Tetsuji Yamashita, Qun Chen, Natalya Belevych, Daniel B Mckim, Andrew J Tarr, Vincenzo Coppola, Nikitaa Nath, Daniel P Nemeth, Zunera W Syed and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Decoding IL-1 receptor 1 and 2 expression profiles across organs in sepsis.Frontiers in cell and developmental biology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Interleukin-1 Receptor Antagonist as Therapy for Traumatic Brain Injury.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2023
    Review
  12. Nanoreporter for Real-Time Monitoring of Inflammasome Activity and Targeted Therapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Xiaoyu LiuDivision of Biosciences, The Ohio State University, Columbus, Ohio 43210, Institute for Behavioral Medicine Research, The Ohio State University Wexner Medical Center, Columbus, Ohio 43210.
Tetsuji YamashitaDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105.
Qun ChenDivision of Biosciences, The Ohio State University, Columbus, Ohio 43210, Institute for Behavioral Medicine Research, The Ohio State University Wexner Medical Center, Columbus, Ohio 43210.
Natalya BelevychDivision of Biosciences, The Ohio State University, Columbus, Ohio 43210, Institute for Behavioral Medicine Research, The Ohio State University Wexner Medical Center, Columbus, Ohio 43210.
Daniel B MckimInstitute for Behavioral Medicine Research, The Ohio State University Wexner Medical Center, Columbus, Ohio 43210, Department of Neuroscience, The Ohio State University, Columbus, Ohio 43210, and.ORCID http://orcid.org/0000-0001-8402-4154
Andrew J TarrDivision of Biosciences, The Ohio State University, Columbus, Ohio 43210, Institute for Behavioral Medicine Research, The Ohio State University Wexner Medical Center, Columbus, Ohio 43210.
Vincenzo CoppolaDepartment of MVIMG, Wexner Medical Center Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210.ORCID http://orcid.org/0000-0001-6163-1779
Nikitaa NathInstitute for Behavioral Medicine Research, The Ohio State University Wexner Medical Center, Columbus, Ohio 43210.
Daniel P NemethInstitute for Behavioral Medicine Research, The Ohio State University Wexner Medical Center, Columbus, Ohio 43210.
Zunera W SyedInstitute for Behavioral Medicine Research, The Ohio State University Wexner Medical Center, Columbus, Ohio 43210.
John F SheridanDivision of Biosciences, The Ohio State University, Columbus, Ohio 43210, Institute for Behavioral Medicine Research, The Ohio State University Wexner Medical Center, Columbus, Ohio 43210.
Jonathan P GodboutInstitute for Behavioral Medicine Research, The Ohio State University Wexner Medical Center, Columbus, Ohio 43210, Department of Neuroscience, The Ohio State University, Columbus, Ohio 43210, and.
Jian ZuoDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105.
Ning QuanDivision of Biosciences, The Ohio State University, Columbus, Ohio 43210, Institute for Behavioral Medicine Research, The Ohio State University Wexner Medical Center, Columbus, Ohio 43210, quan.14@osu.edu.
The Ohio State University Wexner Medical Center · USSt. Jude Children's Research Hospital · US

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
Comprehensive Training in Oral &Craniofacial SciencesT32DE014320 · NIDCR · OHIO STATE UNIVERSITY · PI SHERIDAN, JOHN F · 2001 to 2022
$10.2M
Drug discovery for hair cell regeneration in adult mammalian cochleaeR21DC013879 · NIDCD · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI ZUO, JIAN · 2014 to 2015
$479k
IL-1R1-restore: dissecting cellular mechanisms of IL-1-mediated behavior effectsR21MH099482 · NIMH · OHIO STATE UNIVERSITY · PI QUAN, NING · 2013 to 2014
$422k
NCI NIH HHS P30 CA021765NIDCD NIH HHS R21 DC013879NIDCR NIH HHS T32 DE014320NIDCR NIH HHS T32-DE014320NIMH NIH HHS R21 MH099482NIMH NIH HHS R21-MH099482
6 · The paper itself

Abstract

Interleukin-1 (IL-1) mediates diverse neurophysiological and neuropathological effects in the CNS through type I IL-1 receptor (IL-1R1). However, identification of IL-1R1-expressing cell types and cell-type-specific functions of IL-1R1 remains challenging. In this study, we created a novel genetic mouse model in which IL-1R1 gene expression is disrupted by an intronic insertion of a loxP flanked disruptive sequence that can be deleted by Cre recombinase, resulting in restored IL-1R1 gene expression under its endogenous promoters. A second mutation was introduced at stop codon of the IL-1R1 gene to allow tracking of the restored IL-1R1 protein by a 3HA tag and IL-1R1 mRNA by tdTomato fluorescence. These animals were designated as IL-1R1(r/r) and exhibited an IL-1R1 knock-out phenotype. We used IL-1R1 globally restored mice (IL-1R1(GR/GR)) as an IL-1R1 reporter and observed concordant labeling of IL-1R1 mRNA and protein in brain endothelial cells. Two cell-type-specific IL-1R1 restore lines were generated: Tie2Cre-IL-1R1(r/r) and LysMCre-IL-1R1(r/r). Brain endothelial COX-2 expression, CNS leukocyte infiltration, and global microglia activation induced by intracerebroventricular injection of IL-1β were not observed in IL-1R1(r/r) or LysMCre-IL-1R1(r/r) mice, but were restored in Tie2Cre-IL-1R1(r/r) mice. These results reveal IL-1R1 expression in endothelial cells alone is sufficient to mediate these central IL-1-induced responses. In addition, ex vivo IL-1β stimulation increased IL-1β expression in bone marrow cells in wild-type, Tie2Cre-IL-1R1(r/r), and LysMCre-IL-1R1(r/r), but not IL-1R1(r/r) mice. These results demonstrate this IL-1R1 restore model is a valuable tool for studying cell-type-specific functions of IL-1R1.

Indexed as

AnimalsBone Marrow CellsBrainCalcium-Binding ProteinsCyclooxygenase 2Embryo, MammalianEndothelial CellsEngrailed 2 ProteinFemaleGene Expression RegulationGenotypeHomeodomain ProteinsInterleukin-1betaMaleMiceMice, Inbred C57BLAif1 protein, mouseCalcium-Binding ProteinsCyclooxygenase 2Engrailed 2 ProteinHomeodomain ProteinsIL1R1 protein, mouseInterleukin-1betaMicrofilament ProteinsNerve Tissue ProteinsPtgs2 protein, mouseReceptors, Interleukin-1 Type Iblood–brain barrierendothelial cellsinterleukin 1knock-inneuroinflammationrestore

Identifiers

PMID25698726
PMCPMC4331620
OpenAlexW2158718780

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.